Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZDHHC7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | TMEM74 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | INTS9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ZMAT2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
mRNA | PEAK1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | CYP2U1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | TRMT1L | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | COPG1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | ILKAP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | C20orf194 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |